Amino Acid Infusion in Mothers Before and During Cesarean Delivery
Status:
Completed
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
Introduction: Intravenous infusion of amino acids during cesarean delivery in mothers and
neonates improves neonatal growth. Amino acid before and during anesthesia also prevents
hypothermia and associated untoward effects.
Method: After ethical approval, this prospective randomized double blind controlled study is
being conducted in the university hospital of BPKIHS. Seventy six parturients (ASA 1 & 2)
undergoing cesarean delivery without fetal distress, intrauterine growth retardation,
congenital malformation or premature labor will be enrolled.
For a period starting from approximately one hour prior to spinal anesthesia, Group 1 and
Group 2 patients will receive 200 ml of amino acid and lactated ringers solution respectively
at 2 ml/kg/hr. The ambient operating room temperature will be maintained near 23ยบ C. No
heating methods will be applied apart from covering with a blanket.
Primary outcome measure will be neonatal rectal temperature at 0, 5 and 10 min after birth.
Secondary outcome measures will be APGAR scores and suckling reflex in the newborn, change in
rectal temperature relative to baseline and discomfort related to cold sensation in the
mother and the occurrence of shivering both in the mother and newborn.